Recombinant IL31RA (Nemolizumab Biosimilar) antibody
This Mammalian Cells Monoclonal antibody specifically detects IL31RA (Nemolizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7488064
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL31RA (Nemolizumab Biosimilar) antibody (ABIN7488064)
Target
IL31RA (Nemolizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL31RA (Nemolizumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Nemolizumab Biosimilar - Anti-IL31RA mAb
-
Characteristics
- Antibody Type: IgG2-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG2 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL31RA (Nemolizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
CIM 331
Nemolizumab is an experimental drug for the treatment of itching in people with atopic dermatitis. It is a monoclonal antibody that blocks the interleukin-31 receptor A. -
CAS-No
- 1476039-58-3
Target
-
You are here:
